can you stay on 2.5 tirzepatide TrimRX Can I Stay on the

For example, the risk of acute myocardial infarction was significantly lower in older patients and those with longer treatment durations

Tirzepatide, a dual GIP/GLP-1 agonist, showed up to 20.9% average weight loss in SURMOUNT-1 at 72 weeks

These symptoms are typically most pronounced during the initial weeks of treatment or when doses are increased and usually improve over time

These medications help regulate appetite, slow stomach emptying, and stimulate insulin production in response to meals

Additionally, because semaglutide slows the emptying of the stomach, people tend to feel full for a longer period of time, which can further reduce calorie intake

Kasper EK, Hruban RH, Baughman KL